Brege Laura
Insider transactions at 4 companies
This page shows all SEC Form 4 filings attributed to Brege Laura. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| MIRM | Option Exercise | 17,000 | $15.00 | $255,000 | Sep 11, 2025 | |
| PCRX | Award / Grant | 6,163 | — | — | Jun 11, 2025 | |
| ACAD | Sale | 14,446 | $21.78 | $314,634 | Jun 4, 2025 | |
| MIRM | Option Exercise | 5,703 | — | — | May 29, 2025 | |
| ACAD | Option Exercise | 9,387 | — | — | May 29, 2025 | |
| PCRX | Purchase | 1,000 | $12.81 | $12,810 | Aug 16, 2024 | |
| PCRX | Award / Grant | 5,230 | — | — | Jun 12, 2024 | |
| ACAD | Option Exercise | 6,652 | — | — | May 29, 2024 | |
| PCRX | Award / Grant | 1,775 | — | — | Jun 14, 2023 | |
| ACAD | Sale | 4,500 | $24.87 | $111,915 | Jun 12, 2023 | |
| PCRX | Sale | 600 | $38.74 | $23,244 | Jun 5, 2023 | |
| PCRX | Sale | 7,000 | $40.72 | $285,040 | Apr 3, 2023 | |
| ACAD | Sale | 12,500 | $18.25 | $228,125 | Jan 12, 2023 | |
| PCRX | Award / Grant | 1,160 | — | — | Jun 8, 2022 | |
| ACAD | Option Exercise | 8,552 | — | — | Jun 7, 2022 | |
| PCRX | Award / Grant | 1,066 | — | — | Jun 9, 2021 | |
| PCRX | Sale | 12,000 | $65.95 | $791,400 | Nov 16, 2020 | |
| 0001269021 | Disposition | 7,281 | $18.00 | $131,058 | Jul 2, 2020 | |
| 0001269021 | Award / Grant | 7,281 | — | — | Jun 12, 2020 | |
| PCRX | Award / Grant | 1,260 | — | — | Jun 9, 2020 | |
| PCRX | Sale | 2,100 | $48.70 | $102,270 | Jun 5, 2020 | |
| ACAD | Option Exercise | 10,000 | $1.75 | $17,500 | Jan 7, 2020 | |
| MIRM | Purchase | 10,000 | $11.22 | $112,200 | Sep 10, 2019 | |
| 0001269021 | Award / Grant | 4,194 | — | — | Jun 13, 2019 | |
| PCRX | Award / Grant | 4,134 | — | — | Jun 5, 2019 | |
| ACAD | Sale | 10,000 | $20.00 | $200,000 | Jan 9, 2019 | |
| 0001509190 | Award / Grant | 4,500 | — | — | Jul 27, 2018 | |
| PCRX | Award / Grant | 782 | — | — | Jun 13, 2018 | |
| 0001269021 | Award / Grant | 3,000 | — | — | Jun 8, 2018 | |
| ACAD | Sale | 25,000 | $30.06 | $751,500 | Jan 2, 2018 | |
| 0001509190 | Award / Grant | 4,500 | — | — | Jun 21, 2017 | |
| 0001269021 | Award / Grant | 3,000 | — | — | Jun 16, 2017 | |
| PCRX | Award / Grant | 1,357 | — | — | Jun 14, 2017 | |
| 0001509190 | Award / Grant | 4,500 | — | — | Jun 24, 2016 | |
| 0001269021 | Award / Grant | 3,000 | — | — | Jun 17, 2016 | |
| PCRX | Award / Grant | 1,488 | — | — | Jun 15, 2016 | |
| PCRX | Sale | 1,000 | $46.95 | $46,950 | Jun 6, 2016 | |
| PCRX | Award / Grant | 2,000 | — | — | Jun 3, 2015 | |
| ACAD | Option Exercise | 10,000 | $1.75 | $17,500 | Feb 11, 2015 | |
| ACAD | Option Exercise | 10,000 | $1.75 | $17,500 | Sep 15, 2014 | |
| DCTH | Award / Grant | 9,616 | — | — | Jul 7, 2014 | |
| PCRX | Option Exercise | 3,000 | $13.98 | $41,940 | May 9, 2014 | |
| ACAD | Option Exercise | 14,285 | $1.75 | $24,999 | Apr 4, 2014 | |
| ACAD | Sale | 10,000 | $24.18 | $241,800 | Jan 15, 2014 | |
| ACAD | Option Exercise | 44,117 | $1.36 | $59,999 | Dec 10, 2013 | |
| ACAD | Sale | 10,000 | $21.63 | $216,300 | Oct 10, 2013 | |
| ACAD | Option Exercise | 46,153 | $1.30 | $59,999 | Sep 10, 2013 | |
| DCTH | Award / Grant | 33,000 | — | — | Jun 5, 2013 | |
| 0001012140 | EVP, Corporate Affairs | Sale | 10,000 | $36.01 | $360,100 | Oct 14, 2011 |
| 0001012140 | EVP, Corporate Affairs | Sale | 10,000 | $35.00 | $350,000 | Jul 14, 2011 |